Subsequently, to confirm the findings from the discovery cohorts, we performed immunohistochemistry (IHC) of FGFR1 protein in a validation cohort of 205 pancreatic cancer cases. The gene discussed is FGFR1; the disease is familial pancreatic carcinoma.